Avid Bioservices Inc (CDMO)

[jakedogman1]

compare and contrast sunrise with reported trials to date 2nd line nsclc

http://www.onclive.com/web-exclusives/atezolizumab-improves-survival-in-phase-iii-lung-cancer-study

http://thelancet.com/journals/lancet/article/PIIS0140-6736(16)00587-0/abstract

https://jitc.biomedcentral.com/articles/10.1186/s40425-016-0153-x

https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm525780.htm

my guess is there's a place at the table once they find out where it works best and where others don't work so well..